14-day Premium Trial Subscription Sign Up For FreeGet Free

Agenus Inc. Stock Forecast NASDAQ:AGEN

Price Target and Analyst Ratings

Most Recent Rating

On September 07, 2021 "B. Riley" gave "$11.00 - $12.00" rating for AGEN. The price target was changed from $6.09 to 1.3%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-07 $11.00 - $12.00 Target Raised by B. Riley $6.40 $6.09→1.3%
2021-01-15 Buy Reiterated by B. Riley $3.35 $8.00
2020-12-10 Buy Reiterated by B. Riley $3.41 $8.00
2020-09-23 Buy Reiterated by William Blair $4.29
2020-06-22 Buy Reiterated by B. Riley $4.23 $6.00
2020-06-05 Buy Reiterated by B. Riley $3.85 $6.00
2020-05-22 Buy Reiterated by B. Riley $2.50 $6.00

AGEN Stock Trend

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $5.39 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift.

Given the current short-term trend, the stock is expected to rise 16.77% during the next 3 months and, with a 90% probability hold a price between $6.29 and $7.96 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-20 $5.41 $6.12 $6.83
2021-09-21 $5.42 $6.13 $6.85
2021-09-22 $5.44 $6.15 $6.86
2021-09-23 $5.45 $6.17 $6.88
2021-09-24 $5.47 $6.18 $6.89
2021-09-27 $5.48 $6.20 $6.91
2021-09-28 $5.50 $6.21 $6.93
2021-09-29 $5.51 $6.23 $6.94
2021-09-30 $5.53 $6.24 $6.96
2021-10-01 $5.55 $6.26 $6.97
2021-10-04 $5.56 $6.27 $6.99
2021-10-05 $5.58 $6.29 $7.00
2021-10-06 $5.59 $6.31 $7.02
2021-10-07 $5.61 $6.32 $7.03
2021-10-08 $5.62 $6.34 $7.05
2021-10-11 $5.64 $6.35 $7.07
2021-10-12 $5.65 $6.37 $7.08
2021-10-13 $5.67 $6.38 $7.10
2021-10-14 $5.69 $6.40 $7.11
2021-10-15 $5.70 $6.41 $7.13
2021-10-18 $5.72 $6.43 $7.14
2021-10-19 $5.73 $6.45 $7.16
2021-10-20 $5.75 $6.46 $7.17
2021-10-21 $5.76 $6.48 $7.19
2021-10-22 $5.78 $6.49 $7.20
2021-10-25 $5.79 $6.51 $7.22
2021-10-26 $5.81 $6.52 $7.24
2021-10-27 $5.83 $6.54 $7.25
2021-10-28 $5.84 $6.55 $7.27
2021-10-29 $5.86 $6.57 $7.28

About Agenus Inc.

Agenus Agenus Inc., an immuno-oncology company, focuses on the discovery and development of treatments that engage the body’s immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates using a high-throughput approach incorporating human antibody libraries expressed in mammalian B-lymphocytes. It is also developing Prophage, a hea... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT